This trial is !
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Prostate Cancer
and you are
over 18
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The SPARK trial is testing the use of Kilovoltage Intrafraction Monitoring in prostate cancer patients being treated with Stereotactic Prostate Adaptive Radiotherapy. The researchers expect this trial to result in better targeted prostate cancer patient outcomes with lower toxicity. The potential application of Kilovoltage Intrafraction Monitoring to other tumour sites will pave the way for additional trials with Australasian radiation oncology leading the world.

Provided treatments

  • Radiation: Multi-fraction SABR
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02397317. The sponsor of the trial is University of Sydney and it is looking for 48 volunteers for the current phase.
Official trial title:
Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction